A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.

Oncotarget · 2015 · PMC4466669 · PMID 25749524

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0810

boldest claim

The sentences

highly significantp < 0.001actually significant

The differences in disease-free survival (DFS) and melanoma-specific survival (MSS) were highly significant (DFS: p < 0.001; MSS: p < 0.001; Figure 5B ).

also in 132,142 other papers

showed a trendp = 0.081so close (0.05 < p ≤ 0.1)

Although elevated LDH showed a trend for predicting disease recurrence, it was not significant ( p = 0.081; Figure 6A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.